Anti-inflammatory activity of prosapogenin methyl ester of platycodin D via nuclear factor-kappaB pathway inhibition

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 11, 2008, Pages 2114-2120

  Chung, Ji Won ^a   Noh, Eun Jung ^a   Zhao, Hai Lin ^a   Sim, Joon Soo ^a,b   Ha, Young Wan ^a   Shin, Eun Myoung ^a   Lee, Eun Bang ^a   Cheong, Choon Sik ^c   Kim, Yeong Shik ^a  

^a Seoul National University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c Duksung Women's University   (South Korea)

Author keywords

Animal model; Anti inflammation; Nuclear factor B; Platycodin D; Prosapogenin methyl ester

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLATYCODIN; PLATYCODON GRANDIFLORUM EXTRACT; PROSAPOGENIN D; PROSAPOGENIN D METHYL ESTER; PROSTAGLANDIN E2; SAPOGENIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE EXPRESSION REGULATION; MALE; MOUSE; NONHUMAN; PLATYCODON;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BLOTTING, WESTERN; CYCLOOXYGENASE 2; DINOPROSTONE; EDEMA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, REPORTER; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLATYCODON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAPONINS; TRANSFECTION; TRITERPENES;

EID: 55549133290     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2114     Document Type: Article

References (52)

1. Han J., Ulevitch R. J., Nat. Immunol., 6, 1198-1205 (2005).
2. Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. J., Vane J. R., Proc. Natl. Acad. Sci. U.S.A., 90, 11693-11697 (1993).
3. Dubois R. N., Abramson S. B., Crofford L., Gupta R. A., Simon L. S., Van De Putte L. B., Lipsky P. E., FASEB J., 12, 1063-1073 (1998).
4. Wallace J. L., Am. J. Med., 107, 11S-16S; discussion 16S-17S (1999).
5. Chandrasekharan N. V., Dai H., Roos K. L., Evanson N. K., Tomsik J., Elton T. S., Simmons D. L., Proc. Natl. Acad. Sci. U.S.A., 99, 13926-13931 (2002).
6. Zhou H. Y., Shin E. M., Guo L. Y., Zou L. B., Xu G. H., Lee S. H., Ze K. R., Kim E. K., Kang S. S., Kim Y. S., Eur. J. Pharmacol., 572, 239-248 (2007).
7. Storz P., Toker A., Cell Cycle, 2, 9-10 (2003).
8. Lin A., Karin M., Semin. Cancer Biol., 13, 107-114 (2003).
9. Li Q., Verma I. M., Nat. Rev. Immunol., 2, 725-734 (2002).
10. Yamamoto Y., Gaynor R. B., Curr. Mol. Med., 1, 287-296 (2001).
11. Karin M., Cao Y., Greten F. R., Li Z. W., Nat. Rev. Cancer, 2, 301-310 (2002).
12. Sarkar F. H., Li Y., Mutat. Res., 555, 53-64 (2004).
13. Bharti A. C., Aggarwal B. B., Biochem. Pharmacol., 64, 883-888 (2002).
14. Biswas D. K., Dai S. C., Cruz A., Weiser B., Graner E., Pardee A. B., Proc. Natl. Acad. Sci. U.S.A., 98, 10386-10391 (2001).
15. Haefner B., Drug Discov. Today, 7, 653-663 (2002).
16. Orlowski R. Z., Baldwin A. S. Jr., Trends Mol. Med., 8, 385-389 (2002).
17. Barnes P. J., Karin M., N. Engl. J. Med., 336, 1066-1071 (1997).
18. May M. J., Ghosh S., Immunol. Today, 19, 80-88 (1998).
19. Bensky D., Gamble A., "Chinese Herbal Medicine," Eastland Press, Seattle, 1986.
20. Ishii H., Tori K., Tozyo T., Yoshimura Y. S., J. Chem. Soc., Perkin Trans. 1, 1984, 661-668 (1984).
21. Ishii H., Tori K., Yoshimura Y., J. Chem. Soc., Perkin Trans. 1, 1981, 1928-1933 (1981).
22. Tada A., Kaneiwa Y., Shoji J., Shibata S., Chem. Pharm. Bull., 23, 2965-2972 (1975).
23. Shin C. Y., Lee W. J., Lee E. B., Choi E. Y., Ko K. H., Planta Med., 68, 221-225 (2002).
24. Ahn K. S., Noh E. J., Zhao H. L., Jung S. H., Kang, S. S., Kim Y. S., Life Sci., 76, 2315-2328 (2005).
25. Choi S. S., Han E. J., Lee T. H., Han K. J., Lee H. K., Suh H. W., Am. J. Chin. Med., 32, 257-268 (2004).
26. Kim Y. P., Lee E. B., Kim S. Y., Li D., Ban H. S., Lim S. S., Shin K. H., Ohuchi K., Planta Med., 67, 362-364 (2001).
27. Ahn K. S., Hahn B. S., Kwack K., Lee E. B., Kim Y. S., Eur. J. Pharmacol., 537, 1-11 (2006).
28. Choi C. Y., Kim J. Y., Kim Y. S., Chung Y. C., Hahm K. S., Jeong H. G., Cancer Lett., 166, 17-25 (2001).
29. Choi C. Y., Kim J. Y., Kim Y. S., Chun Y. C., Seo J. K., Jeong H. G., Int. Immunopharmacol., 1, 1141-1151 (2001).
30. Wang C., Schuller Levis G. B., Lee E. B., Levis W. R., Lee D, W., Kim B. S., Park S. Y., Park E., Int. Immunopharmacol., 4, 1039-1049 (2004).
31. Xu B. J., Han L. K., Zheng Y. N., Lee J. H., Sung C. K., Arch. Pharm. Res., 28, 180-185 (2005).
32. Han L. K., Zheng Y. N., Xu B. J., Okuda H., Kimura Y., J. Nutr., 132, 2241-2245 (2002).
33. Han L. K., Xu B. J., Kimura Y., Zheng Y., Okuda H., J. Nutr., 130, 2760-2764 (2000).
34. Zhao H. L., Kim Y. S., Arch. Pharm. Res., 27, 1048-1052 (2004).
35. Zhao H. L., Cho K. H., Ha Y. W., Jeong T. S., Lee W. S., Kim Y. S., Eur. J. Pharmacol., 537, 166-173 (2006).
36. Zhao H. L., Sim J. S., Shim S. H., Ha Y. W., Kang S. S., Kim Y. S., Int. J. Obes. (London), 29, 983-990 (2005).
37. Christie W. W., "Advances in Lipid Methodology," 3rd ed., Vol. VII, ed. by Christie W. W., Oily Press, Dundee, 1993, pp. 69-111.
38. Ishii H., Tozyo T., Yoshimura Y., J. Chem. Soc., Perkin Trans. 1, 1981, 1928 (1981).
39. Moon K. Y., Hahn B. S., Lee J., Kim Y. S., Anal. Biochem., 292, 17-21 (2001).
40. Moon K. Y., Ahn K. S., Lee J., Kim Y. S., Arch. Pharm. Res., 24, 307-311 (2001).
41. Ahn K. S., Moon K. Y., Lee J., Kim Y. S., J. Dermatol. Sci., 31, 193-201 (2003).
42. Andrews N. C., Faller D. V., Nucleic Acids Res., 19, 2499 (1991).
43. Morri C. J., "Inflammation Protocols," ed. by Paul G. W., Derek A. W., Chan C.-C., Isabelle B., Kathryn J. W., Human Press, Totowa, New Jersey, 2003, pp. 115-121, 321-328.
44. Li da W., Hyun J. E., Jeong C. S., Kim Y. S., Lee E. B., Biol. Pharm. Bull., 26, 429-433 (2003).
45. Winter C. A., Risley E. A., Nuss G. W., Proc. Soc. Exp. Biol. Med., 111, 544-547 (1962).
46. Jeon B. H., Kim C. S., Kim H. S., Park J. B., Nam K. Y., Chang S. J., Acta Pharmacol. Sin., 21, 1095-1100 (2000).
47. Kiefer D., Pantuso T., Am. Fam. Physician, 68, 1539-1542 (2003).
48. Geng Y., Zhang B., Lotz M., J. Immunol., 151, 6692-6700 (1993).
49. Stancovski I., Baltimore D., Cell, 91, 299-302 (1997).
50. Pan M. H., Lin-Shiau S. Y., Lin J. K., Biochem. Pharmacol., 60, 1665-1676 (2000).
51. Nantel F., Denis D., Gordon R., Northey A., Cirino M., Metters K. M., Chan C. C., Br. J. Pharmacol., 128, 853-859 (1999).
52. Di Rosa M., Giroud J. P., Willoughby D. A., J. Pathol., 104, 15-29 (1971).